LEP and metabolic dysfunction-associated steatotic liver disease: Furthermore, in the pathogenesis of non-alcoholic fatty liver diseases (NAFLD), leptin plays a key role in obesity development, the levels of which are usually elevated in the plasma of obese individuals [80], inducing HSC activation and promoting NAFLD development [81].